Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation
Abstract: Patients with hematologic malignancies or nonmalignant diseases may undergo allogeneic hematopoietic cell transplantation (HCT), which represents a potential curative treatment.However, they are still at risk of life-threatening complications, such as relapse, acute graft-versus-host disease, and opportunistic infections.These complicatio